Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Biogen Inc](/topic/biogen-inc)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:biogen-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/biogen-inc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +50%  
**1 Month**: XXX% +29%  
**6 Months**: XXX% +59%  
**1 Year**: XXX% +41%  
**1-Year High**: XXX% on 2025-09-15  
**1-Year Low**: XX% on 2025-02-03  

**Most Supportive Themes**
- **LEQEMBI Subcutaneous Injection Availability:** (45%) The availability of LEQEMBI subcutaneous injection in the US for early Alzheimer's disease treatment.
- **Positive Analyst Ratings and Target Price Increases:** (25%) Rothschild Redburn and other analysts have raised their target prices for Biogen Inc (BIIB).
- **Strong Performance in Healthcare Sector:** (15%) The healthcare sector, including Biogen, is experiencing strong performance.
  
**Most Critical Themes**
- **Patent Dispute:** (5%)  Biogen told to pay $124M in patent dispute with Genentech.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
| Reddit  | XX       | X%  | XX      | X%  | X        | X% |
| YouTube | X        | X%  | XX      | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Biogen Inc

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XXX% +29%
6 Months: XXX% +59%
1 Year: XXX% +41%
1-Year High: XXX% on 2025-09-15
1-Year Low: XX% on 2025-02-03

Most Supportive Themes

  • LEQEMBI Subcutaneous Injection Availability: (45%) The availability of LEQEMBI subcutaneous injection in the US for early Alzheimer's disease treatment.
  • Positive Analyst Ratings and Target Price Increases: (25%) Rothschild Redburn and other analysts have raised their target prices for Biogen Inc (BIIB).
  • Strong Performance in Healthcare Sector: (15%) The healthcare sector, including Biogen, is experiencing strong performance.

Most Critical Themes

  • Patent Dispute: (5%) Biogen told to pay $124M in patent dispute with Genentech.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XX X%
Reddit XX X% XX X% X X%
YouTube X X% XX X% X X%
Total XXXXX XX% XXXXX XX% XX X%
Biogen Inc (BIIB) Sentiment
/topic/biogen-inc/sentiment